Furthermore, the CMD provides genetic test forAPC and MUTYH genes (FAP/AFAP),TP53 (LLS/LFL), MLH1, MSH2, MSH6 andPMS2 (Lynch syndrome), CDH1 (Diffuse GastricCancer), RET (for medullary thyroid carcinoma), VHL(for Von Hippel-Lindau syndrome) and PTEN (for Cowden syndrome). This evidence concerns the gene TP53 and medullary thyroid gland carcinoma.